Overexpressed of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability

Abstract

RAD51, a key protein in the homologous recombinational DNA repair (HRR) pathway, is the major strand-transferase required for mitotic recombination. An important early step in HRR is the formation of single-stranded DNA (ss-DNA) coated by RPA (a ss-DNA binding protein). Displacement of RPA by RAD51 is highly regulated and facilitated by a number of different proteins known as the 'recombination mediators'. To assist these recombination mediators, a second group of proteins also is required and we are defining these proteins here as 'recombination co-mediators'. Defects in either recombination mediators or comediators, including BRCA1 and BRCA2, lead to impaired HRR that can genetically be complemented for (i.e. suppressed) by overexpression of RAD51. Defects in HRR have long been known to contribute to genomic instability leading to tumor development. Since genomic instability also slows cell growth, precancerous cells presumably require genomic restabilization to gain a growth advantage. RAD51 is overexpressed in many tumors, and therefore, we hypothesize that the complementing ability of elevated levels of RAD51 in tumors with initial HRR defects limits genomic instability during carcinogenic progression. Of particular interest, this model may also help explain the high frequency of TP53 mutations in human cancers, since wild-type p53 represses RAD51.

Related Papers

• → Recovery of deficient homologous recombination in Brca2-depleted mouse cells by wild-type Rad51 expression(2008)42 cited
• → High Levels of Wild-Type BRCA2 Suppress Homologous Recombination(2012)23 cited
• → Biochemical analysis of the human EVL domains in homologous recombination(2009)3 cited
• → Abstract CN05-04: Opportunities for targeting homologous recombination in human cancers.(2011)
• → Overexpressed of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability(2009)